logo

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Michael G. Aman, Mallikarjuna Rettiganti, Haikady N. Nagaraja, Jill A. Hollway, James T. McCracken, Christopher J. McDougle, Elaine Tierney, Lawrence Scahill, L. Eugene Arnold, Jessica A. Hellings, David J. Posey, Naomi B. Swiezy, Jaswinder K. Ghuman, Marco Grados, Bhavik G. Shah, Benedetto Vitiello
Title
Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.
Journal
Journal of Child and Adolescent Psychopharmacology
Year
2015
Month
August
Volume
25
Issue
6
Page(s)
pp. 482-493.
Full Item
Read Full Item (New Window)
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Peer-Reviewed, Follow-Up
Comments
This a follow up study of the Research Units on Pediatric Psychopharmacology Autism Network (RUPP) (2002)
Keywords
Adaptive Behaviour, Adolescent / Secondary School Age, Antipsychotics, Autism, Child/Children, Intervention, Irritability, Medication, Primary / Elementary School Age, Risperidone, Side Effects

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Interventions


Publications | Publications Database | Search Publications